Clinical phenotype and neuroimaging findings in a French family with hereditary ferritinopathy (FTL498-499InsTC)

Movement Disorders

Volumn 24, Issue 11, 2009, Pages 1676-1683

  Ory Magne, Fabienne ^a   Brefel Courbon, Christine ^a   Payoux, Pierre ^a   Debruxelles, Sabrina ^b   Sibon, Igor ^b   Goizet, Cyril ^b   Labauge, Pierre ^c   Menegon, Patrice ^b   Uro Coste, Emmanuelle ^a   Ghetti, Bernardino ^d   Delisle, Marie Bernadetle ^a   Vidal, Ruben ^d   Rascol, Olivier ^a,e  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Laboratoire de Pharmacologie Medicale et Clinique   (France)

Author keywords

Basal ganglia; Ferritin; Hereditary ferritinopathy; Iron; Neuroferritinopathy

Indexed keywords

FERRITIN; FLUORODEOXYGLUCOSE F 18; HALOPERIDOL; IRON; PAROXETINE; PRIMIDONE; PROPRANOLOL;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN MALFORMATION; CEREBELLAR ATAXIA; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISEASE SEVERITY; DRUG WITHDRAWAL; DYSKINESIA; ESSENTIAL TREMOR; FEMALE; FERRITIN BLOOD LEVEL; FRANCE; GENE MUTATION; GENETIC DISORDER; HEREDITARY FERRITINOPATHY; HUMAN; HUMAN TISSUE; LEUKOENCEPHALOPATHY; LIVER BIOPSY; MALE; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PEDIGREE ANALYSIS; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PYRAMIDAL SIGN; TISSUE LEVEL;

ADULT; AGE OF ONSET; APOFERRITINS; BASAL GANGLIA DISEASES; CENTRAL NERVOUS SYSTEM; CEREBELLAR ATAXIA; DEMENTIA; FEMALE; FERRITINS; FRANCE; HUMANS; IRON; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOVEMENT DISORDERS; MUSCLE, SKELETAL; MUTAGENESIS, INSERTIONAL; MUTATION; PEDIGREE; PHENOTYPE; POSITRON-EMISSION TOMOGRAPHY; SKIN; TREMOR;

EID: 69949153449     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22669     Document Type: Article

References (14)

1. Curtis AR, Fey C, Morris CM, et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 2001;28:350-354.
2. Chinnery PF, Crompton DE, Birchall D, et al. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain 2007;130:110-119.
3. Vidal R, Ghetti B, Takao M, et al. Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol 2004;63:363-380.
4. Mancuso M, Davidzon G, Kurlan RM, et al. Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. J Neuropathol Exp Neurol 2005;64:280-289.
5. Caskey JH, Jones C, Miller YE, Seligman PA. Human ferritin gene is assigned to chromosome 19. Proc Natl Acad Sci USA 1983;80:482-486.
6. Maciel P, Cruz VT, Constante M, et al. Neuroferritinopathy: missense mutation in FTL causing early-onset bilateral pallidal involvement. Neurology 2005;65:603-605.
7. Ohta E, Nagasaka T, Shindo K, et al. Neuroferritinopathy in a Japanese family with a duplication in the ferritin light chain gene. Neurology 2008;70:1493-1494.
8. Kubota A, Hida A, Ichikawa Y, et al. A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: description of clinical features and implications for genotypephenotype correlations. Mov Disord 2009;24:441-445.
9. Devos D, Jissendi Tchofo P, et al. Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation. Brain (in press).
10. Crompton DE, Chinnery PF, Bates D, et al. Spectrum of movement disorders in neuroferritinopathy. Mov Disord 2005;20: 95-99.
11. Mir P, Edwards MJ, Curtis ARJ, Bhatia KP, Quinn NP. Adult-onset generalized dystonia due to a mutation in the neuroferritinopathy gene. Mov Disord 2005;20:243-257.
12. Wills AJ, Sawle GV, Guibert PR, Curtis ARJ. Palatal tremor and cognitive decline in neuroferritinopathy. J Neurol Neurosurg Psychiatry 2002;73:91-92.
13. McNeill A, Birchall D, Hayflick SJ, et al. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 2008;70:1614-1619.
14. Haemers I, Kono S, Goldman S, Gitlin JD, Pandolfo M. Clinical, molecular, and PET study of a case of aceruloplasminemia presenting with focal cranial dyskinesia. J Neurol Neurosurg Psychiatry 2004;75:334-337.